Nanexa AB Surges: 52‑Week High Nearing as Nano‑Drug R&D Drives Investor Confidence
Nanexa AB’s latest rise to SEK 10.42 signals robust biotech momentum—outpacing peers with a strong nanocarrier pipeline poised for near‑term upside.
3 minutes to read